MERIDIAN
BIOSCIENCE, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Ohio
|
0-14902
|
31-0888197
|
||
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.
)
|
3471
River Hills Drive, Cincinnati, Ohio
|
45244
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(Former
name or former address, if changed since last
report.)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
Item
2.02.
|
Results
of Operations and Financial Condition.
|
Item
9.01.
|
Financial
Statements and Exhibits.
|
|
|
99
|
Press
Release
dated April 19, 2007
|
MERIDIAN BIOSCIENCE, INC. | ||
|
|
|
Date: April 20, 2007 | By: | /s/ Melissa Lueke |
Melissa Lueke |
||
Vice
President and Chief Financial Officer
(Principal
Accounting Officer)
|